Biomed Realty Trust Company Profile (NYSE:BMR)

About Biomed Realty Trust (NYSE:BMR)

Biomed Realty Trust logoBioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

Industry, Sector and Symbol:
  • Sector: Financials
  • Industry: Commercial REITs
  • Sub-Industry: Office REITs
  • Symbol: NYSE:BMR
  • CUSIP: 09063H10
  • Web: www.biomedrealty.com/
Capitalization:
  • Market Cap: $4.81 billion
  • Outstanding Shares: 202,210,000
Average Prices:
  • 50 Day Moving Avg: $24.00
  • 200 Day Moving Avg: $22.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 15.77
  • P/E Growth: 0
Dividend:
  • Dividend Yield: 4.4%
Profitability:
  • Net Margins: 18.98%
  • Return on Equity: 3.73%
  • Return on Assets: 2.07%
 

Frequently Asked Questions for Biomed Realty Trust (NYSE:BMR)

What is Biomed Realty Trust's stock symbol?

Biomed Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BMR."

How were Biomed Realty Trust's earnings last quarter?

Biomed Realty Trust Inc (NYSE:BMR) issued its earnings results on Tuesday, April, 28th. The company reported $0.41 EPS for the quarter, topping the Zacks' consensus estimate of $0.37 by $0.04. The business had revenue of $178.01 million for the quarter, compared to analyst estimates of $167.08 million. Biomed Realty Trust had a net margin of 18.98% and a return on equity of 3.73%. The company's quarterly revenue was up 5.4% compared to the same quarter last year. During the same period last year, the company posted $0.38 earnings per share. View Biomed Realty Trust's Earnings History.

Who are some of Biomed Realty Trust's key competitors?

Who are Biomed Realty Trust's key executives?

Biomed Realty Trust's management team includes the folowing people:

  • Greg N. Lubushkin, Chief Financial Officer
  • James R. Berens, President of Wexford Science & Technology
  • Jonathan Paul Klassen, Executive Vice President, General Counsel, Secretary
  • John P. Bonanno, Executive Vice President, Leasing & Development
  • Karen A. Sztraicher, Executive Vice President - Asset Management

How do I buy Biomed Realty Trust stock?

Shares of Biomed Realty Trust can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biomed Realty Trust's stock price today?

One share of Biomed Realty Trust stock can currently be purchased for approximately $23.81.


MarketBeat Community Rating for Biomed Realty Trust (NYSE BMR)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  128 (Vote Outperform)
Underperform Votes:  161 (Vote Underperform)
Total Votes:  289
MarketBeat's community ratings are surveys of what our community members think about Biomed Realty Trust and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Biomed Realty Trust (NYSE:BMR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biomed Realty Trust (NYSE:BMR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
1/22/2016Canaccord GenuityReiterated RatingHoldN/AView Rating Details
10/15/2015KeyCorpUpgradeOverweightN/AView Rating Details
10/10/2015Cowen and CompanyDowngradeOutperform -> Market Perform$24.00N/AView Rating Details
10/9/2015BMO Capital MarketsDowngradeMarket PerformN/AView Rating Details
10/9/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
10/9/2015Robert W. BairdDowngradeOutperform -> Neutral$24.00N/AView Rating Details
9/21/2015MizuhoLower Price TargetNeutral$23.00 -> $21.00N/AView Rating Details
(Data available from 9/20/2015 forward)

Earnings

Earnings History for Biomed Realty Trust (NYSE:BMR)
Earnings by Quarter for Biomed Realty Trust (NYSE:BMR)
Earnings History by Quarter for Biomed Realty Trust (NYSE BMR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/28/2015Q115$0.37$0.41$167.08 million$178.01 millionViewListenView Earnings Details
8/5/2014Q214$0.36$0.40$160.80 million$171.16 millionViewListenView Earnings Details
8/7/2013Q213$0.39$0.37$143.47 million$159.64 millionViewListenView Earnings Details
2/6/2013Q412$0.34$0.36$134.72 million$138.80 millionViewListenView Earnings Details
11/1/2012Q312$0.33$0.34$130.32 million$134.54 millionViewN/AView Earnings Details
8/1/2012$0.29$0.32ViewN/AView Earnings Details
8/3/2011$0.29$0.29ViewN/AView Earnings Details
5/5/2011$0.30$0.30ViewN/AView Earnings Details
2/7/2011$0.28$0.30ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biomed Realty Trust (NYSE:BMR)
Current Year EPS Consensus Estimate: $1.77 EPS
Next Year EPS Consensus Estimate: $1.51 EPS

Dividends

Current Dividend Information for Biomed Realty Trust (NYSE:BMR)
Most Recent Dividend:10/15/2015
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
Track Record:7 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Biomed Realty Trust (NYSE:BMR)

Dividend History by Quarter for Biomed Realty Trust (NYSE BMR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/16/2015quarterly$0.265.35%9/28/20159/30/201510/15/2015
6/16/2015quarterly$0.265.22%6/26/20156/30/20157/15/2015
3/17/2015quarterly$0.264.73%3/27/20153/31/20154/15/2015
12/12/2014special$0.304.88%12/18/201412/22/201412/29/2014
12/12/2014quarterly$0.264.88%12/29/201412/31/20141/15/2015
9/16/2014quarterly$0.254.73%9/26/20149/30/201410/15/2014
6/16/2014quarterly$0.254.54%6/26/20146/30/20147/15/2014
3/17/2014quarterly$0.254.87%3/27/20143/31/20144/15/2014
12/16/2013quarterly$0.255.46%12/27/201312/31/20131/15/2014
9/16/2013quarterly$0.244.83%9/26/20139/30/201310/15/2013
6/17/2013quarterly$0.244.61%6/26/20136/28/20137/15/2013
3/18/2013quarterly$0.244.3%3/26/20133/28/20134/15/2013
12/14/2012quarterly$0.244.95%12/27/201212/31/20121/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Biomed Realty Trust (NYSE:BMR)
Insider Trades by Quarter for Biomed Realty Trust (NYSE:BMR)
Institutional Ownership by Quarter for Biomed Realty Trust (NYSE:BMR)
Insider Trades by Quarter for Biomed Realty Trust (NYSE:BMR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2015John P BonannoEVPSell4,800$21.01$100,848.00View SEC Filing  
6/15/2015James R BerensInsiderSell2,000$19.99$39,980.00View SEC Filing  
6/15/2015John P BonannoEVPSell5,000$19.85$99,250.00View SEC Filing  
3/16/2015Margaret Faye WilsonDirectorBuy2,300$21.76$50,048.00View SEC Filing  
9/8/2014Stephen A WilleyCAOSell1,388$22.50$31,230.00View SEC Filing  
8/13/2014Alan D GoldCEOSell26,615$22.17$590,054.55View SEC Filing  
8/13/2014Matthew G McdevittVPSell16,000$22.01$352,160.00View SEC Filing  
6/3/2014Matthew G McdevittVPSell7,000$21.91$153,370.00View SEC Filing  
5/14/2014Alan GoldCEOSell25,000$21.18$529,500.00View SEC Filing  
5/12/2014Stephen WilleyCAOSell4,840$21.00$101,640.00View SEC Filing  
3/11/2014Stephen WilleyCAOSell7,931$20.25$160,602.75View SEC Filing  
2/11/2014Matthew McdevittVPSell60,000$20.28$1,216,800.00View SEC Filing  
11/23/2012Matthew G McdevittVPSell5,223$19.05$99,498.15View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Biomed Realty Trust (NYSE:BMR)
Latest Headlines for Biomed Realty Trust (NYSE:BMR)
Source:

Social

Chart

Biomed Realty Trust (BMR) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by MarketBeat.com Staff